INTEG B Stock Overview
Researches, develops, and sells various systems for bone-anchored prostheses. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Integrum AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 18.00 |
| 52 Week High | SEK 64.00 |
| 52 Week Low | SEK 17.00 |
| Beta | 1.76 |
| 1 Month Change | -1.64% |
| 3 Month Change | -29.41% |
| 1 Year Change | -62.03% |
| 3 Year Change | -72.85% |
| 5 Year Change | 42.29% |
| Change since IPO | -20.00% |
Recent News & Updates
Recent updates
We're Not Very Worried About Integrum's (STO:INTEG B) Cash Burn Rate
Dec 05
Slammed 38% Integrum AB (publ) (STO:INTEG B) Screens Well Here But There Might Be A Catch
Aug 30We Think Integrum (STO:INTEG B) Can Easily Afford To Drive Business Growth
May 03Does Integrum (STO:INTEG B) Deserve A Spot On Your Watchlist?
Sep 20Integrum's (STO:INTEG B) Earnings Aren't As Good As They Appear
Dec 09Introducing Integrum (STO:INTEG B), The Stock That Soared 873% In The Last Year
Mar 18Shareholder Returns
| INTEG B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 2.9% | 5.6% | 1.1% |
| 1Y | -62.0% | -0.2% | 13.3% |
Return vs Industry: INTEG B underperformed the Swedish Medical Equipment industry which returned -0.2% over the past year.
Return vs Market: INTEG B underperformed the Swedish Market which returned 13.3% over the past year.
Price Volatility
| INTEG B volatility | |
|---|---|
| INTEG B Average Weekly Movement | 6.0% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.7% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: INTEG B has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: INTEG B's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 34 | Scott Flora | www.integrum.se |
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads.
Integrum AB (publ) Fundamentals Summary
| INTEG B fundamental statistics | |
|---|---|
| Market cap | SEK 344.29m |
| Earnings (TTM) | -SEK 15.21m |
| Revenue (TTM) | SEK 104.53m |
3.3x
P/S Ratio-23.0x
P/E RatioIs INTEG B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INTEG B income statement (TTM) | |
|---|---|
| Revenue | SEK 104.53m |
| Cost of Revenue | SEK 16.85m |
| Gross Profit | SEK 87.67m |
| Other Expenses | SEK 102.89m |
| Earnings | -SEK 15.21m |
Last Reported Earnings
Oct 31, 2024
Next Earnings Date
Mar 03, 2025
| Earnings per share (EPS) | -0.78 |
| Gross Margin | 83.88% |
| Net Profit Margin | -14.55% |
| Debt/Equity Ratio | 0% |
How did INTEG B perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 23:28 |
| End of Day Share Price | 2025/01/30 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Integrum AB (publ) is covered by 2 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ulrik Trattner | Carnegie Commissioned Research |
| Oscar Bergman | Redeye |